Biobank for Inflammatory Chronic Diseases and Osteoporosis of TOULouse
NCT: NCT05039216 ·
Status: RECRUITING ·
Phase: N/A
· Sponsor: University Hospital, Toulouse
· Started: 2021-09-13
· Est. Completion: 2031-09-01
Official Summary
The aim of this study is to constitute a biobank for patients followed in the Rheumatology center of Toulouse University Hospital for a chronic inflammatory rheumatism including rheumatoid arthritis (RA), spondyloarthritis(SpA), and psoriatic arthritis (PsA) or a chronic bone disease including osteoporosis in order to identify biomarkers associated with therapeutic response.
Study Design
- Study Type: OBSERVATIONAL
- Enrollment: 2,000 participants
Interventions
- BIOLOGICAL: Blood sampling — 4 tubes of 7 mL will be sampled
Primary Outcomes
- EULAR response after 3 months (after 3 months)
Trial Locations
- Purpan University Hospital, Toulouse, France
More Rheumatoid Arthritis Trials
AI-generated analysis for educational purposes only. This is not medical advice. Discuss clinical trial participation with your doctor. Data sourced from ClinicalTrials.gov.